RCKT FY 2023 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RCKTRocket Pharmaceuticals, Inc.

$572M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$260M

Net Income

-$246M

EPS (Diluted)

$-2.92

Cash Flow

Operating Cash Flow

-$195M

Free Cash Flow

-$211M

Stock-Based Comp.

$39M

Balance Sheet

Total Assets

$566M

Total Liabilities

$74M

Stockholders' Equity

$493M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$260M	-$224M	-15.7%
Net Income	-$246M	-$222M	-10.7%